| Rakesh Chand, | |
|
875 Dearborn Pl, Gilroy, CA 95020-6303 | |
| (408) 318-7637 | |
| Not Available |
| Full Name | Rakesh Chand |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 875 Dearborn Pl, Gilroy, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841652195 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 00000000 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rakesh Chand, 875 Dearborn Pl, Gilroy, CA 95020-6303 Ph: (408) 318-7637 | Rakesh Chand, 875 Dearborn Pl, Gilroy, CA 95020-6303 Ph: (408) 318-7637 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.
The investigational drug ixazomib taken orally in combination with lenalidomide and dexamethasone shows promise in patients with newly diagnosed multiple myeloma, according to the results of a phase 1/2 study published in the journal Lancet Oncology.
Researchers from the UK recently compared the performance of 4 different random priming amplification methods to recover SARS-CoV-2 RNA. In method 1 (H-P), the reverse transcriptase (RT) step included random hexamers, whereas, in methods 2-4, RT incorporated an octamer primer with a known tag. This study is published on the bioRxiv preprint server.
The interior of every cell within our bodies is crisscrossed with a network of molecular highways upon which nutrients, replacement parts, and other vital materials travel to their appropriate location.
Researchers have identified a prognostic marker in the most common form of chronic leukemia that can help to distinguish which patients should start treatment quickly from those who can safely delay treatment, perhaps for years.
› Verified 8 days ago
Kirsten Marcel, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 290 I O O F Ave, Gilroy, CA 95020 Phone: 408-846-2100 | |
Dr. Megan Kaye Abdolrashidi, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 7520 Arroyo Cir, Gilroy, CA 95020 Phone: 408-848-7018 | |
Dr. Sheela Puri, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 8355 Church St, Gilroy, CA 95020 Phone: 408-359-6700 | |
Mary Ngo, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6980 Chestnut St, Gilroy, CA 95020 Phone: 408-776-6201 Fax: 408-778-9672 | |
Heather Ankeny, Psychologist Medicare: Medicare Enrolled Practice Location: 7520 Arroyo Cir, Gilroy, CA 95020 Phone: 408-972-3095 | |
Dr. Paula Lynn Whang-ramos, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8339 Church St, Suite 110, Gilroy, CA 95020 Phone: 408-842-0208 Fax: 408-782-5823 | |
Mckenna Kathleen Baldwin, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1489 Partridge Dr, Gilroy, CA 95020 Phone: 408-826-1840 |